N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine

C25H31Cl2N5O — CID 166871362

IUPACN-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine
SMILESClc1ccc(CN2CCCC(c3ccnc4c(CNCC5CCOCC5)c(Cl)nn34)C2)cc1
InChIInChI=1S/C25H31Cl2N5O/c26-21-5-3-19(4-6-21)16-31-11-1-2-20(17-31)23-7-10-29-25-22(24(27)30-32(23)25)15-28-14-18-8-12-33-13-9-18/h3-7,10,18,20,28H,1-2,8-9,11-17H2
InChIKeyLAQZTIAYMXIVNO-UHFFFAOYSA-N
MW488.46 g/mol
LogP4.93
Rot. Bonds7

About N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine

N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine (PubChem CID 166871362) has the molecular formula C25H31Cl2N5O and a molecular weight of 488.46 g/mol. Its IUPAC name is N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine.

Molecular Properties

Compound NameN-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine
PubChem CID166871362
Molecular FormulaC25H31Cl2N5O
Molecular Weight488.46 g/mol
Exact Mass487.19
IUPAC NameN-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine
SMILESClc1ccc(CN2CCCC(c3ccnc4c(CNCC5CCOCC5)c(Cl)nn34)C2)cc1
InChIInChI=1S/C25H31Cl2N5O/c26-21-5-3-19(4-6-21)16-31-11-1-2-20(17-31)23-7-10-29-25-22(24(27)30-32(23)25)15-28-14-18-8-12-33-13-9-18/h3-7,10,18,20,28H,1-2,8-9,11-17H2
InChIKeyLAQZTIAYMXIVNO-UHFFFAOYSA-N
XLogP4.93
TPSA54.69 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500488.46
LogP ≤ 54.93
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine?
The IUPAC name of N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine (CID 166871362) is N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine.
What is the SMILES notation for N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine?
The canonical SMILES for N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine is Clc1ccc(CN2CCCC(c3ccnc4c(CNCC5CCOCC5)c(Cl)nn34)C2)cc1.
What is the InChIKey of N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine?
The InChIKey is LAQZTIAYMXIVNO-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H31Cl2N5O/c26-21-5-3-19(4-6-21)16-31-11-1-2-20(17-31)23-7-10-29-25-22(24(27)30-32(23)25)15-28-14-18-8-12-33-13-9-18/h3-7,10,18,20,28H,1-2,8-9,11-17H2.
What are the key properties of N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine?
N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine has a molecular weight of 488.46 g/mol, XLogP of 4.93, 7 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[2-chloro-7-[1-[(4-chlorophenyl)methyl]piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-3-yl]methyl]-1-(oxan-4-yl)methanamine is sourced from PubChem (CID 166871362), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).